IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 238 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $183,000 | -13.7% | 19,055 | -0.9% | 0.00% | 0.0% |
| Q2 2022 | $212,000 | -53.8% | 19,234 | -30.2% | 0.00% | 0.0% |
| Q1 2022 | $459,000 | -9.5% | 27,545 | +3.7% | 0.00% | 0.0% |
| Q4 2021 | $507,000 | -33.8% | 26,550 | -14.5% | 0.00% | -50.0% |
| Q3 2021 | $766,000 | +230.2% | 31,067 | +324.1% | 0.00% | +100.0% |
| Q1 2021 | $232,000 | -88.1% | 7,325 | -82.5% | 0.00% | -83.3% |
| Q4 2020 | $1,944,000 | +77.5% | 41,886 | +25.9% | 0.01% | +50.0% |
| Q3 2020 | $1,095,000 | +37.4% | 33,261 | +14.6% | 0.00% | +33.3% |
| Q2 2020 | $797,000 | +140.8% | 29,028 | +162.8% | 0.00% | +50.0% |
| Q1 2020 | $331,000 | – | 11,045 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |